Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Ecosal Plus|October 8, 2015
Vaccines against Infections Caused by Salmonella, Shigella, and Pathogenic Escherichia coliCarlos A Guzman, Stefan Borsutzky, Didier Favre, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2004
TGF-beta receptor signaling is critical for mucosal IgA responsesStefan Borsutzky, Balthazar B Cazac, Jürgen Roes, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2005
The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cellsStefan Borsutzky, Karsten Kretschmer, Pablo D Becker, et al.European Journal of Immunology|October 2, 2002
The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvantFaiza Rharbaoui, Birgit Drabner, Stefan Borsutzky, et al.Vaccine|January 13, 2006
Efficient systemic and mucosal responses against the HIV-1 Tat protein by prime/boost vaccination using the lipopeptide MALP-2 as adjuvantStefan Borsutzky, Thomas Ebensen, Claudia Link, et al.Vaccine|November 10, 2005
Vaccines against typhoid feverCarlos A Guzman, Stefan Borsutzky, Monika Griot-Wenk, et al.European Journal of Immunology|June 5, 2003
Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvantStefan Borsutzky, Valeria Fiorelli, Thomas Ebensen, et al.Pageof 1